NCT03701633 is a clinical trial of Postpartum ultrasound in Breastfeeding, sponsored by Rambam Health Care Campus.

Who is sponsoring NCT03701633?

NCT03701633 is sponsored by Rambam Health Care Campus.

What drugs are being tested in NCT03701633?

Interventions in NCT03701633: Postpartum ultrasound.

What condition does NCT03701633 study?

NCT03701633 studies Breastfeeding.

Is NCT03701633 still recruiting?

NCT03701633 is currently status unknown. Last updated 27 December 2018.

Last reviewed 2018-12-27 · How we verify

NCT03701633

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Uterine Artery Doppler Changes Prior and After Breastfeeding

Status unknown Last updated 27 December 2018

What this trial tests

trial testing Postpartum ultrasound in Breastfeeding in 500 participants. Status unknown.

Timeline

1 November 2018

Primary endpoint
1 October 2019

1 March 2020

Quick facts

Lead sponsor	Rambam Health Care Campus
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	1 November 2018
Primary completion	1 October 2019
Estimated completion	1 March 2020
Sites	1 location across Israel

Drugs / interventions tested

Postpartum ultrasound

Conditions studied

Breastfeeding — all drugs for Breastfeeding →

Sponsor

Rambam Health Care Campus — full company profile →

Who can join

Eligibility, female only, with Breastfeeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We aim to determine whether there are any differences in the UtA doppler measurements in postpartum women prior and right after breastfeeding.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Breastfeeding

Currently open trials in the same condition.

NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
NCT05377372 — Early Life Exposures Among Children With Sickle Cell Disease · NA · recruiting
NCT07341256 — Father-Focused Breastfeeding Education and Breastfeeding Outcomes · NA · recruiting
NCT07499466 — Peer-Support Breastfeeding Program for Mothers in Severe Socioeconomic Deprivation: Feasibility Study · recruiting

Other Rambam Health Care Campus trials

Trials by the same sponsor.

NCT07384013 — Study Protocol: Impact of Metamizole (Optalgin®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs · NA · recruiting
NCT06688253 — Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis · Phase 4 · not yet recruiting
NCT06235749 — Administration Of Calcium Gluconate for The Reduction of Blood Loss During Elective Cesarean Delivery · NA · recruiting
NCT06622902 — Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants. · NA · recruiting
NCT05922111 — Cervical Ripening Balloon for 12 Hours vs. 1 Hour. · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03701633 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rambam Health Care Campus
Last refreshed: 27 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03701633.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing